FGP
MPT

Freestone Grove Partners’s Medical Properties Trust MPT Stock Holding History

Freestone Grove Partners’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.5K Buy
19,374
+12,855
+197% +$63.7K ﹤0.01% 847
2026
Q1 		$30.2K Buy
+6,519
New +$34K ﹤0.01% 853

Other funds holding MPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Freestone Grove Partners's MPT Position: Q2 2026 in Review

Freestone Grove Partners increased its Medical Properties Trust (MPT) stake by 197% in Q2 2026, buying an estimated $63.7K and bringing the position to 19,374 shares worth $89.5K. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Freestone Grove Partners first reported a position in MPT in Q1 2026 and has held it in 2 quarters since. 489 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Freestone Grove Partners held 19,374 shares of Medical Properties Trust worth $89.5K as of Q2 2026.
  • Freestone Grove Partners bought 12,855 Medical Properties Trust shares in Q2 2026, an estimated $63.7K.
  • Medical Properties Trust made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #847 holding.
  • Freestone Grove Partners first reported a position in Medical Properties Trust in Q1 2026 and has held it in 2 quarters since.
  • 489 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.